Results 291 to 300 of about 560,370 (324)
Classification of lung adenocarcinoma based on senescence-related genes identifies a cluster with immunotherapy resistance and poor prognosis. [PDF]
Discov OncolGao X, Shen X, Huang S, Huang S.
europepmc +1 more source
Peripheral blood inflammatory biomarkers neutrophil/ lymphocyte ratio, platelet/lymphocyte ratio and systemic immune-inflammation index/albumin ratio predict prognosis and efficacy in non-small cell lung cancer patients receiving immunotherapy and opioids. [PDF]
BMC CancerLei Y, Cao C, Tang R, Liu Y.
europepmc +1 more source
Future perspectives on immunotherapy for hepatocellular carcinoma. [PDF]
Ther Adv Med OncolChan LL, Chan SL.
europepmc +1 more source
A bibliometric and visual analysis of the impact of senescence on tumor immunotherapy. [PDF]
Front ImmunolLiu Z +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Allergy and Asthma Proceedings, 2022
There are currently no biomarkers that can accurately predict clinical outcomes and segregate responders from nonresponders in allergen immunotherapy (AIT). Therefore, identifying a reliable predictive biomarker is essential to enable clinicians to tailor personalized therapy.
Tiak Ju, Tan +2 more
openaire +2 more sources
There are currently no biomarkers that can accurately predict clinical outcomes and segregate responders from nonresponders in allergen immunotherapy (AIT). Therefore, identifying a reliable predictive biomarker is essential to enable clinicians to tailor personalized therapy.
Tiak Ju, Tan +2 more
openaire +2 more sources
Current Treatment Options in Neurology, 2020
Narcolepsy type 1 (NT1) is a chronic and disabling sleep disorder due to the loss of hypocretinergic neurons in the lateral hypothalamus pathophysiologically linked to an autoimmune process. Current treatment is symptomatic, and no cure is available to date.
Giannoccaro M. P. +4 more
openaire +4 more sources
Narcolepsy type 1 (NT1) is a chronic and disabling sleep disorder due to the loss of hypocretinergic neurons in the lateral hypothalamus pathophysiologically linked to an autoimmune process. Current treatment is symptomatic, and no cure is available to date.
Giannoccaro M. P. +4 more
openaire +4 more sources
2023
Systemic treatment approaches are urgently needed for a subset of meningioma patients who do not achieve local tumor control with surgery and radiotherapy. Classical chemotherapy or anti-angiogenic agents exert only very limited activity in these tumors.
Wirsching, Hans-Georg, Weller, Michael
openaire +3 more sources
Systemic treatment approaches are urgently needed for a subset of meningioma patients who do not achieve local tumor control with surgery and radiotherapy. Classical chemotherapy or anti-angiogenic agents exert only very limited activity in these tumors.
Wirsching, Hans-Georg, Weller, Michael
openaire +3 more sources
Mechanisms of Aeroallergen Immunotherapy
Immunology and Allergy Clinics of North America, 2016Allergen immunotherapy (AIT) is an effective way to treat allergic disorders, targeting the underlying mechanisms and altering the disease course by inducing a long-lasting clinical and immune tolerance to allergens. Although sublingual and subcutaneous routes are used in daily practice, many novel ways to decrease side effects and duration and ...
Cevdet Ozdemir +3 more
openaire +4 more sources
Current Opinion in Otolaryngology & Head & Neck Surgery, 2010
The present article summarizes the 2008-2009 literature on allergen standardization and immunotherapy for inhalant and food sensitivities, with emphasis on delineation of the underlying immunologic changes and on evidence-based conclusions from such and clinical data.The efficacy of subcutaneous immunotherapy for inhalant allergies has been established
openaire +2 more sources
The present article summarizes the 2008-2009 literature on allergen standardization and immunotherapy for inhalant and food sensitivities, with emphasis on delineation of the underlying immunologic changes and on evidence-based conclusions from such and clinical data.The efficacy of subcutaneous immunotherapy for inhalant allergies has been established
openaire +2 more sources